ReviewCancers2020

Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?

Hui Yi Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.